FLGT (Fulgent Genetics) ROCE %: -9.46% (As of Mar. 2026)

What is Fulgent Genetics ROCE %?

Fulgent Genetics FLGT +5.17% 59 ROCE % is -9.46% as of Mar. 2026. GuruFocus rates FLGT with a GF Score™ of 59/100 and a GF Value™ of $23.98 (Modestly Undervalued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Fulgent Genetics's annualized ROCE % for the quarter that ended in Mar. 2026 was -9.46%.

Fulgent Genetics (NAS:FLGT) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Fulgent Genetics ROCE % Related Terms

Fulgent Genetics ROCE % Historical Data

* Premium members only.

The historical data trend for Fulgent Genetics's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fulgent Genetics ROCE % Chart

Fulgent Genetics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

77.53

14.97

-14.11

-6.40

-6.15

Fulgent Genetics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															-4.10	-7.58	-2.64	-10.31	-9.46

59GF Score

Fulgent Genetics Inc FLGT

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Fulgent Genetics ROCE % Calculation

Fulgent Genetics's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	-69.95	/	( ( (1219.964 - 72.899)	+	(1213.525 - 84.967) )	/ 2 )
	=	-69.95	/	( (1147.065	+	1128.558)	/ 2 )
	=	-69.95	/	1137.8115
	=	-6.15 %

Fulgent Genetics's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	-103.844	/	( ( (1213.525 - 84.967)	+	(1156.369 - 90.134) )	/ 2 )
	=	-103.844	/	( ( 1128.558	+	1066.235 )	/ 2 )
	=	-103.844	/	1097.3965
	=	-9.46 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of -9.46% mean?

Fulgent Genetics (FLGT) has a ROCE % of -9.46% as of Mar. 2026.

Is Fulgent Genetics' ROCE % too high?

Fulgent Genetics' current ROCE % is -9.46%. Overall, Fulgent Genetics has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Fulgent Genetics' ROCE % compare to CSTL and MYGN?

Fulgent Genetics' ROCE % of -9.46% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Medical Diagnostics & Research company?

A good ROCE % depends on the Medical Diagnostics & Research industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. Fulgent Genetics's current ROCE % is -9.46%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Fulgent Genetics stock overvalued right now?

Based on GuruFocus' analysis, Fulgent Genetics (FLGT) is currently considered Modestly Undervalued. The stock's GF Value™ is $23.98, compared to a current price of $19.13 — trading 20.2% below its estimated fair value. The current ROCE % is -9.46%. Fulgent Genetics' overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Fulgent Genetics (FLGT), the current ROCE % is -9.46% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fulgent Genetics (FLGT) Overvalued in 2026?

Based on GuruFocus' analysis, Fulgent Genetics stock appears to be undervalued. The current stock price of $19.13 is trading 20.2% below its estimated GF Value™ of $23.98. GuruFocus considers Fulgent Genetics to be Modestly Undervalued.

Key valuation signals for FLGT:

ROCE %: -9.46%
GF Value™: $23.98 vs. price of $19.13 (20.2% below fair value)
GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the FLGT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fulgent Genetics Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies CSTL MYGN PRE IMDX BDSX XGN FONR BNR QUCY IDXG TMO DHR SHSE:603259 XSWX:LONN IDXX A WAT NTRA IQV ILMN

Other Exchanges FLGT:Mexico

Address 4399 Santa Anita Avenue, El Monte, CA, USA, 91731

Website https://www.fulgentgenetics.com

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.

59GF Score

Get the complete analysis for FLGT

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.13

Price

$23.98

GF Value

View FLGT Analysis

See ROCE % data for all stocks →